| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 308.065 | 306.298 | 353.288 | 369.681 | 388.865 | 240.669 | 303.234 | 294.991 | 246.117 | 181.080 |
| Total Income - EUR | 339.872 | 308.439 | 365.664 | 373.306 | 403.300 | 272.240 | 339.403 | 310.719 | 270.292 | 225.142 |
| Total Expenses - EUR | 386.184 | 366.840 | 341.274 | 348.236 | 385.031 | 275.748 | 262.284 | 319.815 | 318.963 | 312.039 |
| Gross Profit/Loss - EUR | -46.313 | -58.401 | 24.390 | 25.070 | 18.268 | -3.507 | 77.119 | -9.096 | -48.670 | -86.897 |
| Net Profit/Loss - EUR | -46.313 | -58.401 | 9.774 | 21.829 | 14.835 | -5.679 | 73.935 | -11.530 | -50.870 | -91.332 |
| Employees | 7 | 6 | 6 | 7 | 5 | 5 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - Geno-L S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 30.478 | 12.202 | 29.731 | 25.495 | 29.435 | 24.158 | 20.507 | 17.774 | 14.959 | 13.037 |
| Current Assets | 132.171 | 93.348 | 165.969 | 168.528 | 91.314 | 128.558 | 134.989 | 113.357 | 106.177 | 73.025 |
| Inventories | 14.826 | 22.009 | 31.087 | 25.574 | 6.238 | 36.755 | 48.203 | 27.050 | 18.856 | 13.311 |
| Receivables | 100.669 | 54.203 | 127.905 | 132.067 | 78.206 | 83.752 | 81.737 | 85.648 | 85.807 | 59.460 |
| Cash | 16.676 | 17.135 | 6.977 | 10.886 | 6.870 | 8.051 | 5.050 | 660 | 1.514 | 254 |
| Shareholders Funds | -40.065 | -98.057 | -86.624 | -63.205 | -47.146 | -51.931 | 23.156 | 11.698 | -39.208 | -130.191 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 248.907 | 254.291 | 337.298 | 303.167 | 229.919 | 251.103 | 182.516 | 190.086 | 205.324 | 239.922 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Geno-L S.r.l.